CN202929038U - Levodopa chemiluminescence detection kit - Google Patents

Levodopa chemiluminescence detection kit Download PDF

Info

Publication number
CN202929038U
CN202929038U CN 201220583955 CN201220583955U CN202929038U CN 202929038 U CN202929038 U CN 202929038U CN 201220583955 CN201220583955 CN 201220583955 CN 201220583955 U CN201220583955 U CN 201220583955U CN 202929038 U CN202929038 U CN 202929038U
Authority
CN
China
Prior art keywords
levodopa
bottle
content
substrate luminescent
bottles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN 201220583955
Other languages
Chinese (zh)
Inventor
叶汝章
叶亚东
张娟
滕凌
全利
朱文华
潘鹂
胡娟
霍世元
李永忠
韦珊
路易斯伊格纳罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANGZHOU ADAM BIOTECH Inc
Original Assignee
CHANGZHOU ADAM BIOTECH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGZHOU ADAM BIOTECH Inc filed Critical CHANGZHOU ADAM BIOTECH Inc
Priority to CN 201220583955 priority Critical patent/CN202929038U/en
Application granted granted Critical
Publication of CN202929038U publication Critical patent/CN202929038U/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The utility model relates to a levodopa content chemiluminescence kit. The kit comprises a microwell plate, an enzyme-labelled antibody working solution, seven standard product solutions with different concentrations, a substrate luminescent solution A, a substrate luminescent solution B and a solid phosphoric acid-Tween buffer solution. A coupling antigen is pre-coated on a microwell strip of the microwell plate by adopting a chemoluminescence method, levodopa contained in a sample and the coupling antigen pre-coated on the microwell strip compete for an enzyme-labelled levodopa antibody, the substrate luminescent solutions are used for luminescence, and the content of a levodopa medicament in the sample can be obtained by utilizing the inverse relationship between a luminescence value and the content of the levodopa. The levodopa content chemiluminescence kit disclosed by the utility model has the characteristics of high speed, high sensitivity and the like, and can play an important role in detecting the content of the levodopa in the biological sample.

Description

A kind of levodopa chemoluminescence method detection kit
Technical field:
The utility model relates to a kind of chemoluminescence method detection technique field of drug test, is specifically related to levodopa chemoluminescence method detection technique field.
Technical background:
Levodopa has another name called levodopa (L-dopa), is antiparkinsonian drug.Enter brain tissue by blood-brain barrier, play a role.Be applicable to primary parkinsonism and non-medicine originality Parkinsonism.The bad reactions such as nauseating, vomiting, poor appetite and insomnia, illusion after taking, this product are arranged.But the toxic and side effect of levodopa is larger, and the treatment window is little.Must the interior levodopa concentration of regular human body.
In long-term regularly human body, levodopa concentration is a clinical conventional sense project.Existing detection method has high-efficient liquid phase technique and vapor-phase chromatography, but has inconvenient and the low characteristics of sensitivity of detecting.
Summary of the invention:
The purpose of this utility model is a kind of levodopa chemoluminescence method detection kit of design, the content of levodopa medicine in detection of biological sample that can be quick, sensitive.
The utility model is a kind of levodopa chemoluminescence method detection kit, comprise 96 hole microwell plates, 10 bottles of reagent in box body and box, 1 bag of solid phosphoric acid-tween damping fluid, 96 hole microwell plates are solid carrier, pre-coated coupling levodopa antigen, 10 bottles of reagent are respectively 7 bottles of standard solutions, 1 bottle of enzyme labelled antibody working fluid, 1 bottle of substrate luminescent solution A, 1 bottle of substrate luminescent solution B.Box body is carton box, and 96 hole microwell plates are placed in the vacuum Fresco Bag, and solid phosphoric acid-tween damping fluid is placed in sealing bag, 7 bottles of standard solutions, and 1 bottle of enzyme labelled antibody working fluid, 1 bottle of substrate luminescent solution A cover PE translucent plastic bottle with deceiving.1 bottle of substrate luminescent solution B covers PE black plastic bottle with deceiving.Microwell plate is comprised of outer gimbal support and dismountable 8 the enzyme mark bars that are placed on it, each dismountable enzyme mark bar has 12 micropores, 7 bottles of standard solutions, 1ml/ bottle, 1 bottle of enzyme labelled antibody working fluid, 10ml, each 1 bottle of substrate luminescent solution A, substrate luminescent solution B, 10ml/ bottle, 1 bottle of stop buffer, 10ml, solid phosphoric acid-1 bag of tween damping fluid, 10g.
The utility model principle is the chemoluminescence method method, pre-coated coupled antigen on microwell plate enzyme mark bar, the levodopa that contains in sample will be competed the anti-levodopa antibody of enzyme target with pre-coated coupled antigen on enzyme mark bar, luminous with the substrate luminescent solution, the sample luminous value becomes negative correlation with the content of its contained levodopa, compare with typical curve, then multiply by its corresponding extension rate, can draw the content of levodopa medicine in sample.
Beneficial effect:
The beneficial effects of the utility model be can be quick, sensitive the detection of biological sample in the content of levodopa medicine.
Description of drawings:
Fig. 1 is the utility model box body schematic diagram, and wherein 1 is box body;
Fig. 2 is the schematic diagram of the utility model 96 hole microwell plates, and wherein 2 is 96 hole microwell plates, and 3 is pre-coated coupling levodopa antigen micropore, and 4 is the outer gimbal support of immobilized enzyme mark bar;
Fig. 3 is the schematic diagram of the utility model solid phosphoric acid-tween damping fluid, and wherein 5 is packed solid phosphoric acid-tween damping fluid;
Fig. 4 is the utility model reagent bottle schematic diagram, and wherein 6 is standard solution, and 7 is enzyme labelled antibody working fluid, substrate luminescent solution A; 8 is substrate luminescent solution B.
Embodiment:
Embodiment 1: a kind of levodopa chemoluminescence method detection kit, 96 hole microwell plates 2,10 bottles of reagent in box body 1 and box, 1 bag of solid phosphoric acid-tween damping fluid 5,96 hole microwell plates are solid carrier, pre-coated coupling levodopa antigen micropore 3,10 bottles of reagent are respectively 6,1 bottles of enzyme labelled antibody working fluids 7 of 7 bottles of standard solutions, 1 bottle of substrate luminescent solution A7,1 bottle of substrate luminescent solution B8.Box body is carton box, and 96 hole microwell plates are placed in the vacuum Fresco Bag, and 6,1 bottles of enzyme labelled antibody working fluids 7 of 7 bottles of standard solutions, 1 bottle of substrate luminescent solution A7 cover PE translucent plastic bottle with deceiving.1 bottle of substrate luminescent solution B8 covers PE black plastic bottle with deceiving.Microwell plate is comprised of outer gimbal support 4 and dismountable 8 the enzyme mark bars that are placed on it, each dismountable enzyme mark bar has 12 micropores, 7 bottles of standard solutions, 1ml/ bottle, 1 bottle of enzyme labelled antibody working fluid, 10ml, each 1 bottle of substrate luminescent solution A, substrate luminescent solution B, 10ml/ bottle, 1 bottle of stop buffer, 10ml, solid phosphoric acid-1 bag of tween damping fluid, 10g.
Human plasma is added in the microwell plate of pre-coated coupling levodopa antigen by 50 μ l/ holes, add simultaneously enzyme labelled antibody working fluid 50 μ l/ holes, 37 ℃, hatch 1h, with cleansing solution washing 3 times, then add substrate luminescent solution 50 μ l/ holes, room temperature 3-5min, Chemiluminescence Apparatus detects, and namely gets levodopa concentration.

Claims (2)

1. levodopa chemoluminescence method detection kit, it is characterized in that: comprise 96 hole microwell plates, 10 bottles of reagent in box body and box, 1 bag of solid phosphoric acid-tween damping fluid is provided with pre-coated coupling levodopa antigen micropore in wherein said 96 hole microwell plates; 10 bottles of reagent are respectively 7 bottles of standard solutions, 1 bottle of enzyme labelled antibody working fluid, 1 bottle of substrate luminescent solution A, 1 bottle of substrate luminescent solution B.
2. a kind of levodopa chemoluminescence method detection kit according to claim 1, it is characterized in that: described 96 hole microwell plates are comprised of outer gimbal support and dismountable 8 the enzyme mark bars that are placed on it, each dismountable enzyme mark bar has 12 micropores, 7 bottles of standard solutions, 1ml/ bottle, 1 bottle of enzyme labelled antibody working fluid, 10ml, each 1 bottle of substrate luminescent solution A, substrate luminescent solution B, 10ml/ bottle, solid phosphoric acid-1 bag of tween damping fluid, 10g.
CN 201220583955 2012-11-08 2012-11-08 Levodopa chemiluminescence detection kit Expired - Lifetime CN202929038U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201220583955 CN202929038U (en) 2012-11-08 2012-11-08 Levodopa chemiluminescence detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201220583955 CN202929038U (en) 2012-11-08 2012-11-08 Levodopa chemiluminescence detection kit

Publications (1)

Publication Number Publication Date
CN202929038U true CN202929038U (en) 2013-05-08

Family

ID=48218987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201220583955 Expired - Lifetime CN202929038U (en) 2012-11-08 2012-11-08 Levodopa chemiluminescence detection kit

Country Status (1)

Country Link
CN (1) CN202929038U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103412118A (en) * 2013-08-13 2013-11-27 厦门市云鹏科技发展有限公司 Shading ELISA plate with transparent bottom and shading ELISA plate apparatus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103412118A (en) * 2013-08-13 2013-11-27 厦门市云鹏科技发展有限公司 Shading ELISA plate with transparent bottom and shading ELISA plate apparatus

Similar Documents

Publication Publication Date Title
JP2015512620A5 (en)
RU2009148286A (en) LIQUID PHARMACEUTICAL COMPOSITION OF BOTULIN TOXIN
EP2987866A3 (en) Method and kit for super-high-sensitivity measurement of protein and nucleic acid, and novel enzyme substrate
AR053948A1 (en) DETECTION OF AN ANCIENT DIANA INDEPENDENTLY FROM THE PRESENCE OR ABSENCE OF A CORRESPONDING THERAPEUTIC ANTIBODY
JP2014513555A5 (en)
CN101533014A (en) Colloidal gold chromatography test paper strip for quickly detecting bisphenol A and preparation method thereof
CN103217414A (en) Chemiluminescent immunoassay method for 3,5,3'-triiodothyronine in blood serum
WO2015091876A9 (en) Mass labels
CN102135543A (en) Real-time and sensitive novel method for detecting biomacromolecule and preparation method for kit
CN202929038U (en) Levodopa chemiluminescence detection kit
CN203211727U (en) Anaerobic transport box
UY29918A1 (en) REAGENT FOR TEST SENSORS CONTAINING CELLULOSE POLYMERS
CN201535774U (en) Spectinomycin ELISA detection kit
RU2009128762A (en) METHOD AND SET FOR IMMUNO-ENZYME DETERMINATION OF FUNCTIONAL ACTIVITY OF HUMAN COMPLEMENT COMPONENT C3
DE502005005225D1 (en) DISPOSABLE fractionator
CN202886380U (en) Diazepam ELISA (enzyme linked immunosorbent assay) kit
CN101403758B (en) Fast detection reagent kit for melamine
CN203890362U (en) Device for detecting microbes by capillary culture method
CN204359795U (en) Mite specific IgG4 subclass antibodies detection kit
CN202649188U (en) Furadantin metabolite detecting kit
CN201756552U (en) Rapid reaction device for gastric helicobacter pylori
CN103675272A (en) Method for testing trace of nanogold particle with specific particle diameter
CN203117153U (en) Biosensor for quickly detecting residual amount of tetracycline and hydroquinone
CN204389433U (en) A kind of clinical medicine detects the equipment of flora fast
CN204625633U (en) A kind of culture tube detected for mycobacterium tuberculosis susceptibility

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20130508